Oval Medical is a cutting edge parenteral-technology company based in Cambridge, UK. Oval was founded by Matthew Young in 2009 with the following key aims:
- To design an autoinjector that is safe and easy to use in all patient populations.
- To provide a less contaminating environment for the storage of all drugs including fragile biologics
- To significantly improve the quality and reliability of autoinjectors
A team of world-leading experts has been pulled together to deliver their revolutionary technology and since 2009 Oval is continuously proving to be a global success. Oval Medical has established a quality management system that complies with the requirements of BS EN 13485:2012, and works with the guidelines and principles from:
- FDA 21 CFR Pt 820
- Medical Device Directive 93/42/EEC
- ANSI/AAMI HE75